Close

Analyst Ratings for BELLUS Health Inc. (BLU) [Sells]

BLU Rating Summary

BLU Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BLU
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $14.75 (+0.1%) * Over Last 12-Mos
Rating Score: 4.3 / 10   Percentile Rank: 43%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
Like BLU Ratings? Also take a look at GSK, JPM, JNJ, GS

BLU Ratings News